Cymabay Therapeu Probability of Future Stock Price Finishing Under 11.56
| CBAYDelisted Stock | USD 11.83 0.27 2.34% |
Cymabay |
Cymabay Therapeu Target Price Odds to finish below 11.56
The tendency of Cymabay Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 11.56 or more in 90 days |
| 11.83 | 90 days | 11.56 | about 92.36 |
Based on a normal probability distribution, the odds of Cymabay Therapeu to drop to $ 11.56 or more in 90 days from now is about 92.36 (This Cymabay Therapeu probability density function shows the probability of Cymabay Stock to fall within a particular range of prices over 90 days) . Probability of Cymabay Therapeu price to stay between $ 11.56 and its current price of $11.83 at the end of the 90-day period is roughly 2.73 .
Given the investment horizon of 90 days Cymabay Therapeu has a beta of -0.36 suggesting as returns on the benchmark increase, returns on holding Cymabay Therapeu are expected to decrease at a much lower rate. During a bear market, however, Cymabay Therapeu is likely to outperform the market. Additionally Cymabay Therapeu has an alpha of 0.4227, implying that it can generate a 0.42 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Cymabay Therapeu Price Density |
| Price |
Predictive Modules for Cymabay Therapeu
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cymabay Therapeu. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cymabay Therapeu Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cymabay Therapeu is not an exception. The market had few large corrections towards the Cymabay Therapeu's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cymabay Therapeu, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cymabay Therapeu within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.42 | |
β | Beta against Dow Jones | -0.36 | |
σ | Overall volatility | 1.20 | |
Ir | Information ratio | 0.05 |
Cymabay Therapeu Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cymabay Therapeu for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cymabay Therapeu can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cymabay Therapeu is not yet fully synchronised with the market data | |
| Cymabay Therapeu has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 31.07 M. Net Loss for the year was (105.37 M) with loss before overhead, payroll, taxes, and interest of (41.63 M). | |
| Cymabay Therapeu currently holds about 153.42 M in cash with (72.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
Cymabay Therapeu Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cymabay Stock often depends not only on the future outlook of the current and potential Cymabay Therapeu's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cymabay Therapeu's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 106.2 M | |
| Cash And Short Term Investments | 394.3 M |
Cymabay Therapeu Technical Analysis
Cymabay Therapeu's future price can be derived by breaking down and analyzing its technical indicators over time. Cymabay Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cymabay Therapeu. In general, you should focus on analyzing Cymabay Stock price patterns and their correlations with different microeconomic environments and drivers.
Cymabay Therapeu Predictive Forecast Models
Cymabay Therapeu's time-series forecasting models is one of many Cymabay Therapeu's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cymabay Therapeu's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cymabay Therapeu
Checking the ongoing alerts about Cymabay Therapeu for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cymabay Therapeu help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cymabay Therapeu is not yet fully synchronised with the market data | |
| Cymabay Therapeu has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 31.07 M. Net Loss for the year was (105.37 M) with loss before overhead, payroll, taxes, and interest of (41.63 M). | |
| Cymabay Therapeu currently holds about 153.42 M in cash with (72.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Transaction History View history of all your transactions and understand their impact on performance |